New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents

Bioorganic & Medicinal Chemistry
2010.0

Abstract

Mycobacterium tuberculosis (M.Tb) is a bacillus capable of causing a chronic and fatal condition in humans known as tuberculosis (TB). It is estimated that there are 8 million new cases of TB per year and 3.1 million infected people die annually. Thirty-six new amide quinoxaline 1,4-di-N-oxide derivatives have been synthesized and evaluated as potential anti-tubercular agents, obtaining biological values similar to the reference compound, Rifampin (RIF).

Knowledge Graph

Similar Paper

New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents
Bioorganic & Medicinal Chemistry 2010.0
Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives
European Journal of Medicinal Chemistry 2010.0
Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents
Bioorganic & Medicinal Chemistry Letters 2010.0
New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents
Bioorganic & Medicinal Chemistry Letters 2011.0
Selective activity against Mycobacterium tuberculosis of new quinoxaline 1,4-di-N-oxides
Bioorganic & Medicinal Chemistry 2009.0
Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents
Bioorganic & Medicinal Chemistry Letters 2016.0
[1,2,3]Triazolo[4,5-h]quinolones. A new class of potent antitubercular agents against multidrug resistant Mycobacterium tuberculosis strains
Bioorganic & Medicinal Chemistry Letters 2007.0
Efficacy of Quinoxaline-2-Carboxylate 1,4-Di- N -Oxide Derivatives in Experimental Tuberculosis
Antimicrobial Agents and Chemotherapy 2008.0
Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis
Bioorganic & Medicinal Chemistry Letters 2016.0
Synthesis of New Quinoxaline-2-carboxylate 1,4-Dioxide Derivatives as Anti-Mycobacterium tuberculosis Agents
Journal of Medicinal Chemistry 2005.0